Miraculous Activist

Timothy Ray Brown, commonly referred to as the “Berlin patient,” does not want to be the only person cured of AIDS.

kerry grens
| 4 min read
timothy ray brown hiv aids activist ccr5 delta32 natural immunity

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: Timothy Ray Brown has gone from medical marvel to HIV/AIDS activist, spreading the hope that researchers can eventually develop a cure for the disease.
SCOTT TABER

In 2006, Timothy Ray Brown was bicycling through Berlin on his lunch break. He regularly cruised the city on two wheels, making a daily 14-mile round trip for work. But on this day, he got off and walked, too tired to make it back to work. “I called my partner and said, ‘I need to get an appointment with a doctor,’” Brown recalls.

Blood tests led to a bone marrow biopsy, which led to a diagnosis of acute myeloid leukemia. From there a remarkable series of circumstances—some fortuitous, others debilitating—catapulted Brown into medical history: to this day he remains the only person who has been cured of AIDS.

Cure is not a word the HIV/AIDS community throws around lightly. “Nobody would dare to use ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours